Actinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual Meeting
19 oct. 2016 07h00 HE
|
Actinium Pharmaceuticals
NEW YORK, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B
18 oct. 2016 07h00 HE
|
Actinium Pharmaceuticals
- Orphan designation is expected to provide increased communication and guidance from regulators and 10-year market exclusivity should marketing authorization be obtained - Orphan designation...
Actinium Announces Closing of Public Offering of Common Stock
04 oct. 2016 16h15 HE
|
Actinium Pharmaceuticals
NEW YORK, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Pricing of Public Offering of Common Stock
29 sept. 2016 08h15 HE
|
Actinium Pharmaceuticals
NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Proposed Public Offering of Common Stock
28 sept. 2016 16h10 HE
|
Actinium Pharmaceuticals
NEW YORK, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60
27 sept. 2016 07h00 HE
|
Actinium Pharmaceuticals
Webinar to be held at 9:00 AM ET to highlight Actimab-A Phase 2 clinical trial and protocol revisions agreed to by the FDAProtocol revisions agreed to by the FDA include the use of peripheral blast...
Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant
26 sept. 2016 07h00 HE
|
Actinium Pharmaceuticals
NEW YORK, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial
21 sept. 2016 08h00 HE
|
Actinium Pharmaceuticals
- Webinar to be Held on Tuesday, September 27, 2016 at 9:00 AM ET - Webinar to feature Principle Investigator Joseph Jurcic, M.D., Professor of Clinical Medicine and Director of the Hematologic...
Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial
20 sept. 2016 07h00 HE
|
Actinium Pharmaceuticals
NEW YORK, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference
19 sept. 2016 07h00 HE
|
Actinium Pharmaceuticals
- Actinium to Present on Tuesday, September 27, 2016 at 1:00 PM ET - Management Will be Available for 1-on-1 Meetings with Conference Attendees NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) --...